nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—DPP4—exocrine gland—uterine cancer	0.0226	0.0565	CbGeAlD
Adenosine—SLC28A3—mammalian vulva—uterine cancer	0.0165	0.0413	CbGeAlD
Adenosine—ADA—myometrium—uterine cancer	0.0158	0.0395	CbGeAlD
Adenosine—Cytarabine—POLD1—uterine cancer	0.0138	0.378	CrCbGaD
Adenosine—ADORA2B—smooth muscle tissue—uterine cancer	0.0131	0.0327	CbGeAlD
Adenosine—ADK—myometrium—uterine cancer	0.0129	0.0323	CbGeAlD
Adenosine—SLC28A3—female gonad—uterine cancer	0.0129	0.0322	CbGeAlD
Adenosine—ADORA2B—decidua—uterine cancer	0.0128	0.032	CbGeAlD
Adenosine—ADORA2B—mammalian vulva—uterine cancer	0.0118	0.0294	CbGeAlD
Adenosine—ADA—decidua—uterine cancer	0.0117	0.0293	CbGeAlD
Adenosine—ADA—renal system—uterine cancer	0.0115	0.0288	CbGeAlD
Adenosine—ADA—mammalian vulva—uterine cancer	0.0107	0.0269	CbGeAlD
Adenosine—ADK—uterine cervix—uterine cancer	0.01	0.0251	CbGeAlD
Adenosine—DPP4—epithelium—uterine cancer	0.00981	0.0246	CbGeAlD
Adenosine—ADK—smooth muscle tissue—uterine cancer	0.00975	0.0244	CbGeAlD
Adenosine—DPP4—uterine cervix—uterine cancer	0.00973	0.0244	CbGeAlD
Adenosine—ADK—decidua—uterine cancer	0.00956	0.0239	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—uterine cancer	0.00946	0.0237	CbGeAlD
Adenosine—ADK—renal system—uterine cancer	0.00939	0.0235	CbGeAlD
Adenosine—DPP4—decidua—uterine cancer	0.00927	0.0232	CbGeAlD
Adenosine—ADA—female reproductive system—uterine cancer	0.0092	0.0231	CbGeAlD
Adenosine—DPP4—renal system—uterine cancer	0.0091	0.0228	CbGeAlD
Adenosine—ADORA2B—vagina—uterine cancer	0.0091	0.0228	CbGeAlD
Adenosine—ADK—endometrium—uterine cancer	0.00908	0.0227	CbGeAlD
Adenosine—ADORA1—renal system—uterine cancer	0.00903	0.0226	CbGeAlD
Adenosine—Clofarabine—RRM2—uterine cancer	0.0088	0.241	CrCbGaD
Adenosine—DPP4—endometrium—uterine cancer	0.0088	0.022	CbGeAlD
Adenosine—ADK—mammalian vulva—uterine cancer	0.00878	0.022	CbGeAlD
Adenosine—DPP4—mammalian vulva—uterine cancer	0.00851	0.0213	CbGeAlD
Adenosine—ADORA2A—female reproductive system—uterine cancer	0.00837	0.021	CbGeAlD
Adenosine—ADA—vagina—uterine cancer	0.00832	0.0208	CbGeAlD
Adenosine—DPP4—uterus—uterine cancer	0.00811	0.0203	CbGeAlD
Adenosine—ADK—female reproductive system—uterine cancer	0.00752	0.0188	CbGeAlD
Adenosine—DPP4—female reproductive system—uterine cancer	0.00729	0.0183	CbGeAlD
Adenosine—ADORA1—female reproductive system—uterine cancer	0.00723	0.0181	CbGeAlD
Adenosine—ADK—female gonad—uterine cancer	0.00684	0.0171	CbGeAlD
Adenosine—ADK—vagina—uterine cancer	0.0068	0.017	CbGeAlD
Adenosine—DPP4—female gonad—uterine cancer	0.00663	0.0166	CbGeAlD
Adenosine—DPP4—vagina—uterine cancer	0.00659	0.0165	CbGeAlD
Adenosine—ADORA1—vagina—uterine cancer	0.00654	0.0164	CbGeAlD
Adenosine—Adenosine triphosphate—ABCC9—uterine cancer	0.00592	0.162	CrCbGaD
Adenosine—ADA—lymph node—uterine cancer	0.00538	0.0135	CbGeAlD
Adenosine—Cladribine—RRM2—uterine cancer	0.00505	0.138	CrCbGaD
Adenosine—ADK—lymph node—uterine cancer	0.0044	0.011	CbGeAlD
Adenosine—DPP4—lymph node—uterine cancer	0.00426	0.0107	CbGeAlD
Adenosine—ADORA1—lymph node—uterine cancer	0.00423	0.0106	CbGeAlD
Adenosine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.00814	CcSEcCtD
Adenosine—Numbness—Etoposide—uterine cancer	0.00405	0.00806	CcSEcCtD
Adenosine—Apnoea—Etoposide—uterine cancer	0.00396	0.00788	CcSEcCtD
Adenosine—Abdominal discomfort—Progesterone—uterine cancer	0.00394	0.00785	CcSEcCtD
Adenosine—Sensory loss—Etoposide—uterine cancer	0.00387	0.00771	CcSEcCtD
Adenosine—Pain—Carboplatin—uterine cancer	0.00381	0.00758	CcSEcCtD
Adenosine—Pollakiuria—Progesterone—uterine cancer	0.0038	0.00757	CcSEcCtD
Adenosine—Chest discomfort—Etoposide—uterine cancer	0.00379	0.00755	CcSEcCtD
Adenosine—Drowsiness—Progesterone—uterine cancer	0.00367	0.0073	CcSEcCtD
Adenosine—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00367	0.0073	CcSEcCtD
Adenosine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00712	CcSEcCtD
Adenosine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.00686	CcSEcCtD
Adenosine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00662	CcSEcCtD
Adenosine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00652	CcSEcCtD
Adenosine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.00649	CcSEcCtD
Adenosine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00634	CcSEcCtD
Adenosine—Tinnitus—Progesterone—uterine cancer	0.00307	0.00611	CcSEcCtD
Adenosine—Cardiac disorder—Progesterone—uterine cancer	0.00306	0.00608	CcSEcCtD
Adenosine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00605	CcSEcCtD
Adenosine—Mediastinal disorder—Progesterone—uterine cancer	0.00297	0.00591	CcSEcCtD
Adenosine—ADK—Nucleotide metabolism—RRM2—uterine cancer	0.00295	0.0476	CbGpPWpGaD
Adenosine—Adenosine triphosphate—AKT1—uterine cancer	0.00293	0.0803	CrCbGaD
Adenosine—Tension—Progesterone—uterine cancer	0.00281	0.0056	CcSEcCtD
Adenosine—DPP4—Peptide hormone metabolism—INHBA—uterine cancer	0.0028	0.0451	CbGpPWpGaD
Adenosine—Nervousness—Progesterone—uterine cancer	0.00278	0.00554	CcSEcCtD
Adenosine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00278	0.00554	CcSEcCtD
Adenosine—Back pain—Progesterone—uterine cancer	0.00277	0.00552	CcSEcCtD
Adenosine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00277	0.00551	CcSEcCtD
Adenosine—Hyperventilation—Epirubicin—uterine cancer	0.00273	0.00544	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—RNF43—uterine cancer	0.00271	0.0436	CbGpPWpGaD
Adenosine—Burning sensation—Epirubicin—uterine cancer	0.00271	0.00539	CcSEcCtD
Adenosine—Vision blurred—Progesterone—uterine cancer	0.0027	0.00538	CcSEcCtD
Adenosine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00535	CcSEcCtD
Adenosine—Tremor—Progesterone—uterine cancer	0.00268	0.00535	CcSEcCtD
Adenosine—DPP4—Peptide hormone metabolism—MME—uterine cancer	0.00263	0.0424	CbGpPWpGaD
Adenosine—Angioedema—Progesterone—uterine cancer	0.00262	0.00522	CcSEcCtD
Adenosine—Syncope—Progesterone—uterine cancer	0.00257	0.00512	CcSEcCtD
Adenosine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00508	CcSEcCtD
Adenosine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00506	CcSEcCtD
Adenosine—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00254	0.00506	CcSEcCtD
Adenosine—Palpitations—Progesterone—uterine cancer	0.00253	0.00504	CcSEcCtD
Adenosine—Hyperventilation—Doxorubicin—uterine cancer	0.00253	0.00503	CcSEcCtD
Adenosine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00502	CcSEcCtD
Adenosine—Loss of consciousness—Progesterone—uterine cancer	0.00252	0.00502	CcSEcCtD
Adenosine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.005	CcSEcCtD
Adenosine—Burning sensation—Doxorubicin—uterine cancer	0.0025	0.00499	CcSEcCtD
Adenosine—Cough—Progesterone—uterine cancer	0.0025	0.00498	CcSEcCtD
Adenosine—Cardiac failure—Etoposide—uterine cancer	0.00249	0.00497	CcSEcCtD
Adenosine—Convulsion—Progesterone—uterine cancer	0.00248	0.00495	CcSEcCtD
Adenosine—Scotoma—Epirubicin—uterine cancer	0.00248	0.00493	CcSEcCtD
Adenosine—Hypertension—Progesterone—uterine cancer	0.00247	0.00493	CcSEcCtD
Adenosine—Chest pain—Progesterone—uterine cancer	0.00244	0.00486	CcSEcCtD
Adenosine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.00485	CcSEcCtD
Adenosine—Anxiety—Progesterone—uterine cancer	0.00243	0.00484	CcSEcCtD
Adenosine—Discomfort—Progesterone—uterine cancer	0.00241	0.0048	CcSEcCtD
Adenosine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00475	CcSEcCtD
Adenosine—Dry mouth—Progesterone—uterine cancer	0.00239	0.00475	CcSEcCtD
Adenosine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00473	CcSEcCtD
Adenosine—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00235	0.00468	CcSEcCtD
Adenosine—Anaphylactic shock—Progesterone—uterine cancer	0.00234	0.00466	CcSEcCtD
Adenosine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00464	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—uterine cancer	0.00232	0.0373	CbGpPWpGaD
Adenosine—Cardiac arrest—Etoposide—uterine cancer	0.00231	0.00461	CcSEcCtD
Adenosine—Shock—Progesterone—uterine cancer	0.0023	0.00458	CcSEcCtD
Adenosine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00457	CcSEcCtD
Adenosine—Scotoma—Doxorubicin—uterine cancer	0.00229	0.00456	CcSEcCtD
Adenosine—Tachycardia—Progesterone—uterine cancer	0.00228	0.00455	CcSEcCtD
Adenosine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00455	CcSEcCtD
Adenosine—Hyperhidrosis—Progesterone—uterine cancer	0.00226	0.0045	CcSEcCtD
Adenosine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00448	CcSEcCtD
Adenosine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.0044	CcSEcCtD
Adenosine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00439	CcSEcCtD
Adenosine—Hypotension—Progesterone—uterine cancer	0.00219	0.00435	CcSEcCtD
Adenosine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.00435	CcSEcCtD
Adenosine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00431	CcSEcCtD
Adenosine—Flushing—Dactinomycin—uterine cancer	0.00216	0.0043	CcSEcCtD
Adenosine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—uterine cancer	0.00215	0.0346	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00213	0.00424	CcSEcCtD
Adenosine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00422	CcSEcCtD
Adenosine—Paraesthesia—Progesterone—uterine cancer	0.0021	0.00418	CcSEcCtD
Adenosine—Dyspnoea—Progesterone—uterine cancer	0.00209	0.00415	CcSEcCtD
Adenosine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00415	CcSEcCtD
Adenosine—Ventricular extrasystoles—Epirubicin—uterine cancer	0.00208	0.00414	CcSEcCtD
Adenosine—Somnolence—Progesterone—uterine cancer	0.00208	0.00414	CcSEcCtD
Adenosine—Bronchospasm—Etoposide—uterine cancer	0.00207	0.00412	CcSEcCtD
Adenosine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00412	CcSEcCtD
Adenosine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00408	CcSEcCtD
Adenosine—ADA—Nucleotide metabolism—RRM2—uterine cancer	0.00201	0.0323	CbGpPWpGaD
Adenosine—Pain—Progesterone—uterine cancer	0.002	0.00398	CcSEcCtD
Adenosine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00394	CcSEcCtD
Adenosine—Atrioventricular block—Epirubicin—uterine cancer	0.00194	0.00386	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00385	CcSEcCtD
Adenosine—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00193	0.00384	CcSEcCtD
Adenosine—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—uterine cancer	0.00191	0.0308	CbGpPWpGaD
Adenosine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00379	CcSEcCtD
Adenosine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00376	CcSEcCtD
Adenosine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00375	CcSEcCtD
Adenosine—Ventricular tachycardia—Epirubicin—uterine cancer	0.00188	0.00374	CcSEcCtD
Adenosine—Injection site reaction—Epirubicin—uterine cancer	0.00187	0.00372	CcSEcCtD
Adenosine—Urticaria—Progesterone—uterine cancer	0.00186	0.0037	CcSEcCtD
Adenosine—Acute coronary syndrome—Etoposide—uterine cancer	0.00185	0.00368	CcSEcCtD
Adenosine—Myocardial infarction—Etoposide—uterine cancer	0.00184	0.00366	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—uterine cancer	0.00179	0.00357	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00174	0.00346	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—uterine cancer	0.00173	0.00344	CcSEcCtD
Adenosine—Hypersensitivity—Progesterone—uterine cancer	0.00172	0.00343	CcSEcCtD
Adenosine—Discomfort—Dactinomycin—uterine cancer	0.0017	0.00339	CcSEcCtD
Adenosine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00335	CcSEcCtD
Adenosine—Asthenia—Progesterone—uterine cancer	0.00168	0.00334	CcSEcCtD
Adenosine—Hypoaesthesia—Etoposide—uterine cancer	0.00168	0.00334	CcSEcCtD
Adenosine—Cardiac disorder—Etoposide—uterine cancer	0.00156	0.00311	CcSEcCtD
Adenosine—Flushing—Etoposide—uterine cancer	0.00156	0.00311	CcSEcCtD
Adenosine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00311	CcSEcCtD
Adenosine—Dizziness—Progesterone—uterine cancer	0.00155	0.00308	CcSEcCtD
Adenosine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00303	CcSEcCtD
Adenosine—Mediastinal disorder—Etoposide—uterine cancer	0.00152	0.00302	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00151	0.003	CcSEcCtD
Adenosine—Vomiting—Progesterone—uterine cancer	0.00149	0.00296	CcSEcCtD
Adenosine—Rash—Progesterone—uterine cancer	0.00147	0.00294	CcSEcCtD
Adenosine—Dermatitis—Progesterone—uterine cancer	0.00147	0.00293	CcSEcCtD
Adenosine—Headache—Progesterone—uterine cancer	0.00147	0.00292	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—STAR—uterine cancer	0.00144	0.0232	CbGpPWpGaD
Adenosine—Dysgeusia—Etoposide—uterine cancer	0.00144	0.00286	CcSEcCtD
Adenosine—Back pain—Etoposide—uterine cancer	0.00142	0.00282	CcSEcCtD
Adenosine—Pain—Dactinomycin—uterine cancer	0.00141	0.00282	CcSEcCtD
Adenosine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00279	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—uterine cancer	0.0014	0.00278	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—uterine cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Nausea—Progesterone—uterine cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00268	CcSEcCtD
Adenosine—Affect lability—Epirubicin—uterine cancer	0.00134	0.00267	CcSEcCtD
Adenosine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00266	CcSEcCtD
Adenosine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00266	CcSEcCtD
Adenosine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00264	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—uterine cancer	0.0013	0.00258	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—uterine cancer	0.00129	0.00258	CcSEcCtD
Adenosine—Mood swings—Epirubicin—uterine cancer	0.00129	0.00257	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—uterine cancer	0.00129	0.00257	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00129	0.00257	CcSEcCtD
Adenosine—Cough—Etoposide—uterine cancer	0.00128	0.00255	CcSEcCtD
Adenosine—Convulsion—Etoposide—uterine cancer	0.00127	0.00253	CcSEcCtD
Adenosine—Hypertension—Etoposide—uterine cancer	0.00127	0.00252	CcSEcCtD
Adenosine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00251	CcSEcCtD
Adenosine—Chest pain—Etoposide—uterine cancer	0.00125	0.00249	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—uterine cancer	0.00124	0.00248	CcSEcCtD
Adenosine—Discomfort—Etoposide—uterine cancer	0.00123	0.00246	CcSEcCtD
Adenosine—Hypersensitivity—Dactinomycin—uterine cancer	0.00122	0.00243	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—uterine cancer	0.0012	0.00239	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—uterine cancer	0.0012	0.00238	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—uterine cancer	0.0012	0.00238	CcSEcCtD
Adenosine—Asthenia—Dactinomycin—uterine cancer	0.00119	0.00236	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—TSPYL2—uterine cancer	0.00118	0.0191	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—HNF1B—uterine cancer	0.00117	0.0189	CbGpPWpGaD
Adenosine—Tachycardia—Etoposide—uterine cancer	0.00117	0.00233	CcSEcCtD
Adenosine—Hyperhidrosis—Etoposide—uterine cancer	0.00116	0.0023	CcSEcCtD
Adenosine—Hypotension—Etoposide—uterine cancer	0.00112	0.00223	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—uterine cancer	0.00109	0.00217	CcSEcCtD
Adenosine—Paraesthesia—Etoposide—uterine cancer	0.00107	0.00214	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—STAR—uterine cancer	0.00107	0.0172	CbGpPWpGaD
Adenosine—Dyspnoea—Etoposide—uterine cancer	0.00107	0.00212	CcSEcCtD
Adenosine—Somnolence—Etoposide—uterine cancer	0.00106	0.00212	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—uterine cancer	0.00105	0.00209	CcSEcCtD
Adenosine—Vomiting—Dactinomycin—uterine cancer	0.00105	0.00209	CcSEcCtD
Adenosine—Rash—Dactinomycin—uterine cancer	0.00104	0.00208	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—uterine cancer	0.00104	0.0167	CbGpPWpGaD
Adenosine—Pain—Etoposide—uterine cancer	0.00102	0.00204	CcSEcCtD
Adenosine—Sweating—Epirubicin—uterine cancer	0.00101	0.00201	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—uterine cancer	0.00101	0.00201	CcSEcCtD
Adenosine—Nausea—Dactinomycin—uterine cancer	0.000982	0.00196	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—uterine cancer	0.000973	0.00194	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—uterine cancer	0.000961	0.00191	CcSEcCtD
Adenosine—Urticaria—Etoposide—uterine cancer	0.00095	0.00189	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—uterine cancer	0.000939	0.00187	CcSEcCtD
Adenosine—Sweating—Doxorubicin—uterine cancer	0.000933	0.00186	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—uterine cancer	0.00093	0.015	CbGpPWpGaD
Adenosine—Bradycardia—Doxorubicin—uterine cancer	0.000889	0.00177	CcSEcCtD
Adenosine—Hypersensitivity—Etoposide—uterine cancer	0.000881	0.00176	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—uterine cancer	0.00088	0.00175	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—uterine cancer	0.000876	0.00174	CcSEcCtD
Adenosine—Flushing—Epirubicin—uterine cancer	0.000876	0.00174	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000876	0.0141	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—HNF1B—uterine cancer	0.000873	0.0141	CbGpPWpGaD
Adenosine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000869	0.00173	CcSEcCtD
Adenosine—Asthenia—Etoposide—uterine cancer	0.000858	0.00171	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—uterine cancer	0.000851	0.00169	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—uterine cancer	0.000843	0.00168	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—STAR—uterine cancer	0.000827	0.0133	CbGpPWpGaD
Adenosine—Tinnitus—Doxorubicin—uterine cancer	0.000814	0.00162	CcSEcCtD
Adenosine—Flushing—Doxorubicin—uterine cancer	0.000811	0.00161	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—uterine cancer	0.000811	0.00161	CcSEcCtD
Adenosine—Tension—Epirubicin—uterine cancer	0.000806	0.00161	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—uterine cancer	0.000805	0.0016	CcSEcCtD
Adenosine—Nervousness—Epirubicin—uterine cancer	0.000798	0.00159	CcSEcCtD
Adenosine—Back pain—Epirubicin—uterine cancer	0.000795	0.00158	CcSEcCtD
Adenosine—Dizziness—Etoposide—uterine cancer	0.000791	0.00158	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000787	0.00157	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—uterine cancer	0.00078	0.00155	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—uterine cancer	0.000774	0.00154	CcSEcCtD
Adenosine—Vomiting—Etoposide—uterine cancer	0.000761	0.00152	CcSEcCtD
Adenosine—Agitation—Epirubicin—uterine cancer	0.000755	0.0015	CcSEcCtD
Adenosine—Rash—Etoposide—uterine cancer	0.000754	0.0015	CcSEcCtD
Adenosine—Dermatitis—Etoposide—uterine cancer	0.000754	0.0015	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—EZH2—uterine cancer	0.000753	0.0121	CbGpPWpGaD
Adenosine—Headache—Etoposide—uterine cancer	0.00075	0.00149	CcSEcCtD
Adenosine—Tension—Doxorubicin—uterine cancer	0.000746	0.00149	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—uterine cancer	0.000745	0.00148	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—uterine cancer	0.000738	0.00147	CcSEcCtD
Adenosine—Syncope—Epirubicin—uterine cancer	0.000737	0.00147	CcSEcCtD
Adenosine—Back pain—Doxorubicin—uterine cancer	0.000735	0.00146	CcSEcCtD
Adenosine—Palpitations—Epirubicin—uterine cancer	0.000726	0.00145	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—EP300—uterine cancer	0.000723	0.0116	CbGpPWpGaD
Adenosine—Loss of consciousness—Epirubicin—uterine cancer	0.000722	0.00144	CcSEcCtD
Adenosine—Cough—Epirubicin—uterine cancer	0.000717	0.00143	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—uterine cancer	0.000717	0.00143	CcSEcCtD
Adenosine—Convulsion—Epirubicin—uterine cancer	0.000712	0.00142	CcSEcCtD
Adenosine—Nausea—Etoposide—uterine cancer	0.000711	0.00142	CcSEcCtD
Adenosine—Hypertension—Epirubicin—uterine cancer	0.000709	0.00141	CcSEcCtD
Adenosine—Chest pain—Epirubicin—uterine cancer	0.0007	0.00139	CcSEcCtD
Adenosine—Agitation—Doxorubicin—uterine cancer	0.000699	0.00139	CcSEcCtD
Adenosine—Anxiety—Epirubicin—uterine cancer	0.000697	0.00139	CcSEcCtD
Adenosine—Discomfort—Epirubicin—uterine cancer	0.000691	0.00138	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—uterine cancer	0.000684	0.00136	CcSEcCtD
Adenosine—Syncope—Doxorubicin—uterine cancer	0.000682	0.00136	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—HNF1B—uterine cancer	0.000674	0.0109	CbGpPWpGaD
Adenosine—Palpitations—Doxorubicin—uterine cancer	0.000672	0.00134	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—uterine cancer	0.000671	0.00134	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—uterine cancer	0.000668	0.00133	CcSEcCtD
Adenosine—Cough—Doxorubicin—uterine cancer	0.000663	0.00132	CcSEcCtD
Adenosine—Shock—Epirubicin—uterine cancer	0.00066	0.00131	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—uterine cancer	0.000659	0.00131	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—uterine cancer	0.000656	0.00131	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—uterine cancer	0.000655	0.0013	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000653	0.0105	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—CTNNB1—uterine cancer	0.000649	0.0104	CbGpPWpGaD
Adenosine—Hyperhidrosis—Epirubicin—uterine cancer	0.000648	0.00129	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—uterine cancer	0.000647	0.00129	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—uterine cancer	0.000645	0.00128	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—uterine cancer	0.00064	0.00127	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—uterine cancer	0.000633	0.00126	CcSEcCtD
Adenosine—Hypotension—Epirubicin—uterine cancer	0.000627	0.00125	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000621	0.00124	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000611	0.00122	CcSEcCtD
Adenosine—Shock—Doxorubicin—uterine cancer	0.000611	0.00122	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—uterine cancer	0.000606	0.00121	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—uterine cancer	0.000602	0.0012	CcSEcCtD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—EP300—uterine cancer	0.000601	0.00968	CbGpPWpGaD
Adenosine—Hyperhidrosis—Doxorubicin—uterine cancer	0.0006	0.00119	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—uterine cancer	0.000598	0.00119	CcSEcCtD
Adenosine—Somnolence—Epirubicin—uterine cancer	0.000596	0.00119	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—uterine cancer	0.00058	0.00115	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000578	0.00931	CbGpPWpGaD
Adenosine—Pain—Epirubicin—uterine cancer	0.000574	0.00114	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000571	0.0092	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	0.00057	0.00917	CbGpPWpGaD
Adenosine—ADK—Metabolism—SRD5A2—uterine cancer	0.000568	0.00914	CbGpPWpGaD
Adenosine—ADK—Metabolism—NDUFB11—uterine cancer	0.000568	0.00914	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000565	0.00113	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—EZH2—uterine cancer	0.00056	0.00902	CbGpPWpGaD
Adenosine—Paraesthesia—Doxorubicin—uterine cancer	0.000557	0.00111	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—uterine cancer	0.000553	0.0011	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—uterine cancer	0.000552	0.0011	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—EP300—uterine cancer	0.000533	0.00859	CbGpPWpGaD
Adenosine—Urticaria—Epirubicin—uterine cancer	0.000533	0.00106	CcSEcCtD
Adenosine—Pain—Doxorubicin—uterine cancer	0.000531	0.00106	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—INHBA—uterine cancer	0.000529	0.00852	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—EP300—uterine cancer	0.000508	0.00818	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000506	0.00815	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—MME—uterine cancer	0.000497	0.00801	CbGpPWpGaD
Adenosine—Hypersensitivity—Epirubicin—uterine cancer	0.000494	0.000984	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—uterine cancer	0.000493	0.000982	CcSEcCtD
Adenosine—Asthenia—Epirubicin—uterine cancer	0.000481	0.000958	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—NRAS—uterine cancer	0.000475	0.00765	CbGpPWpGaD
Adenosine—Hypersensitivity—Doxorubicin—uterine cancer	0.000457	0.000911	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—uterine cancer	0.000445	0.000887	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—EP300—uterine cancer	0.000444	0.00715	CbGpPWpGaD
Adenosine—Dizziness—Epirubicin—uterine cancer	0.000443	0.000883	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—EZH2—uterine cancer	0.000432	0.00696	CbGpPWpGaD
Adenosine—Vomiting—Epirubicin—uterine cancer	0.000426	0.000849	CcSEcCtD
Adenosine—Rash—Epirubicin—uterine cancer	0.000423	0.000842	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—uterine cancer	0.000422	0.000841	CcSEcCtD
Adenosine—Headache—Epirubicin—uterine cancer	0.00042	0.000837	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—NRAS—uterine cancer	0.000416	0.00669	CbGpPWpGaD
Adenosine—Dizziness—Doxorubicin—uterine cancer	0.00041	0.000817	CcSEcCtD
Adenosine—ADK—Metabolism—STAR—uterine cancer	0.00041	0.00661	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKR1B1—uterine cancer	0.00041	0.00661	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—KRAS—uterine cancer	0.000409	0.00658	CbGpPWpGaD
Adenosine—Nausea—Epirubicin—uterine cancer	0.000398	0.000793	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—uterine cancer	0.000395	0.000786	CcSEcCtD
Adenosine—Rash—Doxorubicin—uterine cancer	0.000391	0.000779	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—uterine cancer	0.000391	0.000779	CcSEcCtD
Adenosine—Headache—Doxorubicin—uterine cancer	0.000389	0.000774	CcSEcCtD
Adenosine—ADA—Metabolism—NDUFB11—uterine cancer	0.000386	0.00621	CbGpPWpGaD
Adenosine—ADA—Metabolism—SRD5A2—uterine cancer	0.000386	0.00621	CbGpPWpGaD
Adenosine—Nausea—Doxorubicin—uterine cancer	0.000369	0.000734	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—KRAS—uterine cancer	0.000358	0.00576	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—HRAS—uterine cancer	0.000348	0.0056	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—YWHAE—uterine cancer	0.000328	0.00527	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—FBXW7—uterine cancer	0.000327	0.00526	CbGpPWpGaD
Adenosine—ADK—Metabolism—POLD1—uterine cancer	0.000322	0.00518	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—HRAS—uterine cancer	0.000304	0.0049	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKR1C1—uterine cancer	0.000301	0.00485	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKR1B1—uterine cancer	0.000279	0.00449	CbGpPWpGaD
Adenosine—ADA—Metabolism—STAR—uterine cancer	0.000279	0.00449	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR2—uterine cancer	0.000279	0.00449	CbGpPWpGaD
Adenosine—ADK—Metabolism—RRM2—uterine cancer	0.000268	0.00432	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—PTEN—uterine cancer	0.000265	0.00427	CbGpPWpGaD
Adenosine—ADK—Metabolism—DCN—uterine cancer	0.000261	0.0042	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—EP300—uterine cancer	0.000253	0.00407	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP11A1—uterine cancer	0.000245	0.00395	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKR1C3—uterine cancer	0.000232	0.00373	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000229	0.00368	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKR1B10—uterine cancer	0.000219	0.00353	CbGpPWpGaD
Adenosine—ADA—Metabolism—POLD1—uterine cancer	0.000219	0.00352	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—FGFR2—uterine cancer	0.000214	0.00345	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKR1C1—uterine cancer	0.000205	0.0033	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—PTEN—uterine cancer	0.000197	0.00317	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000195	0.00313	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—CXCL8—uterine cancer	0.000193	0.00311	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—EP300—uterine cancer	0.000188	0.00303	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKR1B10—uterine cancer	0.000187	0.003	CbGpPWpGaD
Adenosine—ADA—Metabolism—RRM2—uterine cancer	0.000182	0.00294	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RNF43—uterine cancer	0.000182	0.00293	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000181	0.00291	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—uterine cancer	0.000181	0.00291	CbGpPWpGaD
Adenosine—ADK—Metabolism—STK11—uterine cancer	0.000181	0.00291	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP19A1—uterine cancer	0.000181	0.00291	CbGpPWpGaD
Adenosine—ADA—Metabolism—DCN—uterine cancer	0.000177	0.00285	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—uterine cancer	0.000175	0.00282	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL2—uterine cancer	0.000174	0.0028	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CCL2—uterine cancer	0.000168	0.0027	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP11A1—uterine cancer	0.000167	0.00269	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—INHBA—uterine cancer	0.000166	0.00268	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—uterine cancer	0.000162	0.00261	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKR1C3—uterine cancer	0.000158	0.00254	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RNF43—uterine cancer	0.000155	0.00249	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000154	0.00248	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—PTEN—uterine cancer	0.000152	0.00245	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.00015	0.00242	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKR1C1—uterine cancer	0.00015	0.00241	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—uterine cancer	0.000149	0.0024	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL2—uterine cancer	0.000148	0.00238	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—EP300—uterine cancer	0.000145	0.00234	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1B10—uterine cancer	0.000144	0.00232	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—INHBA—uterine cancer	0.000141	0.00228	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL8—uterine cancer	0.000138	0.00222	CbGpPWpGaD
Adenosine—ADK—Metabolism—MTHFR—uterine cancer	0.000136	0.00219	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—uterine cancer	0.000135	0.00217	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—uterine cancer	0.000135	0.00217	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—uterine cancer	0.000133	0.00214	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CXCL8—uterine cancer	0.000133	0.00214	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKR1C1—uterine cancer	0.000127	0.00205	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1B—uterine cancer	0.000125	0.00201	CbGpPWpGaD
Adenosine—ADA—Metabolism—STK11—uterine cancer	0.000123	0.00198	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP19A1—uterine cancer	0.000123	0.00198	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CTNNB1—uterine cancer	0.000123	0.00197	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RNF43—uterine cancer	0.000119	0.00192	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000119	0.00191	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—uterine cancer	0.000117	0.00189	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKR1C3—uterine cancer	0.000115	0.00186	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTEN—uterine cancer	0.000115	0.00185	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—uterine cancer	0.000115	0.00184	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL2—uterine cancer	0.000114	0.00184	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PGR—uterine cancer	0.000112	0.00181	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—INHBA—uterine cancer	0.000109	0.00176	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—YWHAE—uterine cancer	0.000107	0.00173	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	0.000105	0.00169	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—uterine cancer	0.000104	0.00167	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FBXW7—uterine cancer	0.000103	0.00165	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NRAS—uterine cancer	0.000102	0.00165	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1C1—uterine cancer	9.83e-05	0.00158	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKR1C3—uterine cancer	9.8e-05	0.00158	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	9.74e-05	0.00157	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PGR—uterine cancer	9.55e-05	0.00154	CbGpPWpGaD
Adenosine—ADA—Metabolism—MTHFR—uterine cancer	9.23e-05	0.00149	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—YWHAE—uterine cancer	9.11e-05	0.00147	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—uterine cancer	9.04e-05	0.00146	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STK11—uterine cancer	8.98e-05	0.00145	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL2—uterine cancer	8.94e-05	0.00144	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—uterine cancer	8.81e-05	0.00142	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FBXW7—uterine cancer	8.74e-05	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	8.6e-05	0.00138	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SOCS3—uterine cancer	8.41e-05	0.00135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—uterine cancer	8.1e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN2B—uterine cancer	8.05e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—uterine cancer	7.82e-05	0.00126	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—uterine cancer	7.78e-05	0.00125	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STK11—uterine cancer	7.64e-05	0.00123	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL2—uterine cancer	7.6e-05	0.00122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1C3—uterine cancer	7.57e-05	0.00122	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—uterine cancer	7.55e-05	0.00122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—uterine cancer	7.49e-05	0.00121	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PGR—uterine cancer	7.38e-05	0.00119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMAD3—uterine cancer	7.35e-05	0.00118	CbGpPWpGaD
Adenosine—ADK—Metabolism—EP300—uterine cancer	7.2e-05	0.00116	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOCS3—uterine cancer	7.15e-05	0.00115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—uterine cancer	7.07e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—YWHAE—uterine cancer	7.04e-05	0.00113	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR2—uterine cancer	7.01e-05	0.00113	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN2B—uterine cancer	6.85e-05	0.0011	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FBXW7—uterine cancer	6.75e-05	0.00109	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—uterine cancer	6.65e-05	0.00107	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—uterine cancer	6.62e-05	0.00107	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—uterine cancer	6.61e-05	0.00106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMAD3—uterine cancer	6.25e-05	0.00101	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—uterine cancer	6.01e-05	0.000968	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—uterine cancer	6e-05	0.000966	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR2—uterine cancer	5.96e-05	0.00096	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STK11—uterine cancer	5.9e-05	0.000949	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL2—uterine cancer	5.87e-05	0.000945	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—NRAS—uterine cancer	5.67e-05	0.000913	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOCS3—uterine cancer	5.52e-05	0.000889	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—uterine cancer	5.33e-05	0.000858	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN2B—uterine cancer	5.29e-05	0.000851	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL2—uterine cancer	5.28e-05	0.00085	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—uterine cancer	5.13e-05	0.000826	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—uterine cancer	5.13e-05	0.000826	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—uterine cancer	5.11e-05	0.000823	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—uterine cancer	5.1e-05	0.000821	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—uterine cancer	4.94e-05	0.000795	CbGpPWpGaD
Adenosine—ADA—Metabolism—EP300—uterine cancer	4.89e-05	0.000788	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—uterine cancer	4.88e-05	0.000786	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMAD3—uterine cancer	4.83e-05	0.000777	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—NRAS—uterine cancer	4.82e-05	0.000776	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—uterine cancer	4.64e-05	0.000747	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR2—uterine cancer	4.6e-05	0.000741	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL2—uterine cancer	4.49e-05	0.000723	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—uterine cancer	4.48e-05	0.000722	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—uterine cancer	4.4e-05	0.000709	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—uterine cancer	4.35e-05	0.000701	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—uterine cancer	4.2e-05	0.000676	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—uterine cancer	4.18e-05	0.000672	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—uterine cancer	4.15e-05	0.000668	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—uterine cancer	4.15e-05	0.000668	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—uterine cancer	4.08e-05	0.000656	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—uterine cancer	4.03e-05	0.000649	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—uterine cancer	3.94e-05	0.000634	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—uterine cancer	3.85e-05	0.00062	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—uterine cancer	3.81e-05	0.000614	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—uterine cancer	3.75e-05	0.000604	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—uterine cancer	3.74e-05	0.000603	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—NRAS—uterine cancer	3.72e-05	0.000599	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—uterine cancer	3.66e-05	0.00059	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—uterine cancer	3.62e-05	0.000583	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EP300—uterine cancer	3.58e-05	0.000576	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—uterine cancer	3.55e-05	0.000572	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—uterine cancer	3.53e-05	0.000568	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL2—uterine cancer	3.47e-05	0.000558	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—uterine cancer	3.47e-05	0.000558	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—uterine cancer	3.43e-05	0.000552	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—uterine cancer	3.39e-05	0.000546	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NRAS—uterine cancer	3.35e-05	0.000539	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—uterine cancer	3.28e-05	0.000527	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—uterine cancer	3.24e-05	0.000522	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—uterine cancer	3.2e-05	0.000516	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—uterine cancer	3.19e-05	0.000514	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—uterine cancer	3.11e-05	0.000501	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EP300—uterine cancer	3.04e-05	0.00049	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—uterine cancer	2.96e-05	0.000476	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.94e-05	0.000474	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—uterine cancer	2.89e-05	0.000465	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—uterine cancer	2.88e-05	0.000464	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—uterine cancer	2.88e-05	0.000464	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRAS—uterine cancer	2.85e-05	0.000459	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—uterine cancer	2.74e-05	0.000441	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—uterine cancer	2.72e-05	0.000438	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—uterine cancer	2.68e-05	0.000431	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—uterine cancer	2.65e-05	0.000426	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—uterine cancer	2.65e-05	0.000426	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—uterine cancer	2.56e-05	0.000413	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—uterine cancer	2.53e-05	0.000407	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—uterine cancer	2.46e-05	0.000397	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—uterine cancer	2.45e-05	0.000395	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—uterine cancer	2.45e-05	0.000395	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—uterine cancer	2.4e-05	0.000387	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EP300—uterine cancer	2.35e-05	0.000378	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—uterine cancer	2.25e-05	0.000363	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—uterine cancer	2.23e-05	0.000358	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRAS—uterine cancer	2.2e-05	0.000354	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—uterine cancer	2.18e-05	0.000351	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—uterine cancer	2.16e-05	0.000348	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—uterine cancer	2.08e-05	0.000335	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—uterine cancer	1.89e-05	0.000305	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—uterine cancer	1.84e-05	0.000296	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—uterine cancer	1.74e-05	0.00028	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—uterine cancer	1.68e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—uterine cancer	1.61e-05	0.000259	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—uterine cancer	1.42e-05	0.000229	CbGpPWpGaD
